Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
499 | 19953 | 32.5 | 70% |
Classes in level above (level 4) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
0 | 3633673 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//MED |
Classes in level below (level 2) |
ID, lev. below |
Publications | Label for level below |
---|---|---|
903 | 10618 | DIHYDROPYRIMIDINE DEHYDROGENASE//5 FLUOROURACIL//THYMIDINE PHOSPHORYLASE |
2118 | 4652 | BINUCLEATED LYMPHOCYTES//HUMANIZED MICE//CHEMOSENSITIVITY TEST |
2795 | 2580 | CAMPTOTHECIN//SN 38//TOPOTECAN |
2999 | 2103 | CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY//VINFLUNINE//VINCRISTINE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | DIHYDROPYRIMIDINE DEHYDROGENASE | Author keyword | 554 | 84% | 1% | 298 |
2 | 5 FLUOROURACIL | Author keyword | 531 | 33% | 7% | 1349 |
3 | THYMIDINE PHOSPHORYLASE | Author keyword | 494 | 74% | 2% | 368 |
4 | IRINOTECAN | Author keyword | 354 | 39% | 4% | 718 |
5 | S 1 | Author keyword | 332 | 55% | 2% | 412 |
6 | OXALIPLATIN | Author keyword | 292 | 34% | 3% | 693 |
7 | THYMIDYLATE SYNTHASE | Author keyword | 289 | 48% | 2% | 443 |
8 | CAMPTOTHECIN | Author keyword | 236 | 40% | 2% | 466 |
9 | LEUCOVORIN | Author keyword | 228 | 54% | 1% | 291 |
10 | CAPECITABINE | Author keyword | 226 | 36% | 3% | 505 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | DIHYDROPYRIMIDINE DEHYDROGENASE | 554 | 84% | 1% | 298 | Search DIHYDROPYRIMIDINE+DEHYDROGENASE | Search DIHYDROPYRIMIDINE+DEHYDROGENASE |
2 | 5 FLUOROURACIL | 531 | 33% | 7% | 1349 | Search 5+FLUOROURACIL | Search 5+FLUOROURACIL |
3 | THYMIDINE PHOSPHORYLASE | 494 | 74% | 2% | 368 | Search THYMIDINE+PHOSPHORYLASE | Search THYMIDINE+PHOSPHORYLASE |
4 | IRINOTECAN | 354 | 39% | 4% | 718 | Search IRINOTECAN | Search IRINOTECAN |
5 | S 1 | 332 | 55% | 2% | 412 | Search S+1 | Search S+1 |
6 | OXALIPLATIN | 292 | 34% | 3% | 693 | Search OXALIPLATIN | Search OXALIPLATIN |
7 | THYMIDYLATE SYNTHASE | 289 | 48% | 2% | 443 | Search THYMIDYLATE+SYNTHASE | Search THYMIDYLATE+SYNTHASE |
8 | CAMPTOTHECIN | 236 | 40% | 2% | 466 | Search CAMPTOTHECIN | Search CAMPTOTHECIN |
9 | LEUCOVORIN | 228 | 54% | 1% | 291 | Search LEUCOVORIN | Search LEUCOVORIN |
10 | CAPECITABINE | 226 | 36% | 3% | 505 | Search CAPECITABINE | Search CAPECITABINE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | FLUOROURACIL | 868 | 30% | 12% | 2404 |
2 | 5 FLUOROURACIL | 664 | 27% | 11% | 2121 |
3 | FOLINIC ACID | 471 | 47% | 4% | 741 |
4 | LEUCOVORIN | 456 | 33% | 6% | 1123 |
5 | DIHYDROPYRIMIDINE DEHYDROGENASE | 402 | 60% | 2% | 434 |
6 | BIOCHEMICAL MODULATION | 365 | 76% | 1% | 258 |
7 | HIGH DOSE LEUCOVORIN | 319 | 58% | 2% | 369 |
8 | CPT 11 | 297 | 50% | 2% | 432 |
9 | 5 DEOXY 5 FLUOROURIDINE | 263 | 80% | 1% | 165 |
10 | ADVANCED COLORECTAL CANCER | 259 | 40% | 3% | 510 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 82 | 11% | 4% | 734 |
2 | CLINICAL COLORECTAL CANCER | 16 | 20% | 0% | 75 |
3 | GASTRIC CANCER | 15 | 16% | 0% | 85 |
4 | GI CANCER | 2 | 13% | 0% | 13 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
5-Fluorouracil: Mechanisms of action and clinical strategies | 2003 | 1149 | 96 | 70% |
A Review of the Evolution of Systemic Chemotherapy in the Management of Colorectal Cancer | 2015 | 3 | 61 | 69% |
Humanized mice for immune system investigation: progress, promise and challenges | 2012 | 112 | 123 | 65% |
Patient-derived tumour xenografts as models for oncology drug development | 2012 | 142 | 106 | 46% |
Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms? | 2015 | 4 | 187 | 47% |
Chemotherapy-induced neuropathy: A comprehensive survey | 2014 | 22 | 99 | 66% |
Humanized mice in translational biomedical research | 2007 | 460 | 125 | 35% |
Basic science and clinical management of painful and non-painful chemotherapy-related neuropathy | 2015 | 3 | 80 | 46% |
Clinical pharmacokinetics and metabolism of irinotecan (CPT-11) | 2001 | 339 | 132 | 70% |
Chemotherapy-induced peripheral neuropathy: Prevention and treatment strategies | 2008 | 165 | 52 | 73% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PATHOGEN BIOCHEM MED | 41 | 100% | 0.1% | 15 |
2 | CANC 2 | 19 | 74% | 0.1% | 14 |
3 | UNIT NEUROONCOL | 16 | 61% | 0.1% | 17 |
4 | GASTROINTESTINAL ONCOL | 15 | 13% | 0.5% | 105 |
5 | GERCOR | 15 | 77% | 0.1% | 10 |
6 | STEHLIN FDN CANC | 13 | 69% | 0.1% | 11 |
7 | EPIDEMIOL CLIN INFORMAT MANAGEMENT | 11 | 38% | 0.1% | 23 |
8 | DANIEL DEN HOED KLIN | 11 | 28% | 0.2% | 33 |
9 | TOKUSHIMA | 11 | 18% | 0.3% | 53 |
10 | ONCOPHARMACOL | 10 | 22% | 0.2% | 38 |
Related classes at same level (level 3) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000004278 | NM23//RIBONUCLEOTIDE REDUCTASE//DEOXYCYTIDINE KINASE |
2 | 0.0000003895 | COLONOSCOPY//BARRETTS ESOPHAGUS//ESOPHAGEAL CANCER |
3 | 0.0000003150 | NON SMALL CELL LUNG CANCER//BRAIN METASTASES//LUNG CANCER |
4 | 0.0000002626 | SOLID LIPID NANOPARTICLES//L ASPARAGINASE//NANOSTRUCTURED LIPID CARRIERS |
5 | 0.0000002257 | KERNICTERUS//HYPERBILIRUBINEMIA//BILIRUBIN |
6 | 0.0000002142 | RECTAL CANCER//INCISIONAL HERNIA//TOTAL MESORECTAL EXCISION |
7 | 0.0000002055 | P GLYCOPROTEIN//MULTIDRUG RESISTANCE//SGLT2 INHIBITOR |
8 | 0.0000001972 | BREAST CANCER//BREAST//BRCA1 |
9 | 0.0000001936 | HOMOCYSTEINE//FOLATE//FOLIC ACID |
10 | 0.0000001919 | CYTOMETRY//ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY//CYTOMETRY PART A |